HH
NVO

Hilltop Holdings’s Novo Nordisk NVO Stock Holding History

Hilltop Holdings’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$217K Sell
5,902
-5,517
-48% -$261K 0.02% 596
2025
Q4 		$581K Sell
11,419
-3,892
-25% -$199K 0.03% 504
2025
Q3 		$850K Sell
15,311
-15,363
-50% -$899K 0.04% 404
2025
Q2 		$2.12M Buy
30,674
+3,739
+14% +$254K 0.14% 170
2025
Q1 		$1.87M Buy
26,935
+15,505
+136% +$1.28M 0.12% 190
2024
Q4 		$983K Buy
11,430
+3,452
+43% +$373K 0.06% 329
2024
Q3 		$950K Buy
7,978
+4,054
+103% +$541K 0.06% 329
2024
Q2 		$560K Buy
3,924
+1,570
+67% +$208K 0.06% 335
2024
Q1 		$302K Buy
+2,354
New +$280K 0.03% 502
2022
Q1 		– Sell
-15,928
Closed -$892K – 605
2021
Q4 		$892K Buy
15,928
+958
+6% +$51.9K 0.09% 203
2021
Q3 		$718K Buy
14,970
+986
+7% +$47.7K 0.08% 244
2021
Q2 		$586K Buy
13,984
+5,942
+74% +$230K 0.07% 286
2021
Q1 		$271K Buy
+8,042
New +$286K 0.04% 435
2020
Q4 		– Sell
-8,652
Closed -$300K – 506
2020
Q3 		$300K Sell
8,652
-38
-0.4% -$1.27K 0.05% 324
2020
Q2 		$284K Buy
+8,690
New +$277K 0.05% 302
2020
Q1 		– Sell
-8,866
Closed -$256K – 421
2019
Q4 		$256K Sell
8,866
-2,516
-22% -$69.7K 0.05% 328
2019
Q3 		$294K Buy
11,382
+692
+6% +$17.5K 0.06% 309
2019
Q2 		$273K Sell
10,690
-2,244
-17% -$55.5K 0.06% 286
2019
Q1 		$339K Sell
12,934
-2,072
-14% -$50.9K 0.07% 260
2018
Q4 		$346K Sell
15,006
-732
-5% -$16.3K 0.09% 223
2018
Q3 		$371K Sell
15,738
-722
-4% -$17.6K 0.08% 282
2018
Q2 		$380K Sell
16,460
-1,054
-6% -$25.1K 0.08% 260
2018
Q1 		$431K Sell
17,514
-764
-4% -$20.1K 0.08% 252
2017
Q4 		$491K Buy
18,278
+2,998
+20% +$76.2K 0.11% 215
2017
Q3 		$368K Sell
15,280
-260
-2% -$5.88K 0.11% 194
2017
Q2 		$333K Sell
15,540
-220
-1% -$4.44K 0.1% 246
2017
Q1 		$270K Buy
15,760
+132
+0.8% +$2.3K 0.08% 266
2016
Q4 		$280K Buy
15,628
+132
+0.9% +$2.39K 0.09% 253
2016
Q3 		$323K Sell
15,496
-1,382
-8% -$34.3K 0.1% 232
2016
Q2 		$454K Sell
16,878
-4,430
-21% -$121K 0.14% 188
2016
Q1 		$578K Buy
21,308
+408
+2% +$10.9K 0.18% 166
2015
Q4 		$607K Buy
20,900
+1,148
+6% +$31.8K 0.18% 167
2015
Q3 		$536K Buy
19,752
+4,258
+27% +$121K 0.16% 178
2015
Q2 		$424K Buy
15,494
+18
+0.1% +$506 0.12% 205
2015
Q1 		$413K Sell
15,476
-1,310
-8% -$30.2K 0.11% 226
2014
Q4 		$355K Buy
16,786
+82
+0.5% +$1.83K 0.12% 145
2014
Q3 		$398K Sell
16,704
-9,344
-36% -$215K 0.18% 131
2014
Q2 		$601K Sell
26,048
-1,318
-5% -$29.1K 0.28% 98
2014
Q1 		$624K Sell
27,366
-5,314
-16% -$113K 0.31% 93
2013
Q4 		$604K Buy
32,680
+960
+3% +$16.7K 0.31% 90
2013
Q3 		$537K Buy
31,720
+180
+0.6% +$3.03K 0.31% 89
2013
Q2 		$488K Buy
+31,540
New +$525K 0.33% 77

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DAM
Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

Hilltop Holdings's NVO Position: Q1 2026 in Review

Hilltop Holdings reduced its Novo Nordisk (NVO) stake by 48% in Q1 2026, selling an estimated $261K and leaving 5,902 shares worth $217K. The position accounts for 0.02% of the portfolio, ranked #596.

Hilltop Holdings first reported a position in NVO in Q2 2013 and has held it in 42 quarters since. The position peaked at $2.12M in Q2 2025. 1,271 funds tracked by Wall St. Rank hold NVO as of Q1 2026.

  • Hilltop Holdings held 5,902 shares of Novo Nordisk worth $217K as of Q1 2026.
  • Hilltop Holdings sold 5,517 Novo Nordisk shares in Q1 2026, an estimated $261K.
  • Novo Nordisk made up 0.02% of Hilltop Holdings's portfolio in Q1 2026, its #596 holding.
  • Hilltop Holdings first reported a position in Novo Nordisk in Q2 2013 and has held it in 42 quarters since.
  • Hilltop Holdings's Novo Nordisk position peaked at $2.12M in Q2 2025.
  • 1,271 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.

Based on Hilltop Holdings's 13F filing for Q1 2026, filed 14 May 2026.